TMIST Breast Cancer Screening Trial Enrollment Surpasses 100,000

The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has now enrolled more than 100,000 women in the United States and abroad. One of the fastest-growing National Cancer Institute-sponsored trials, TMIST has expanded to 130 participating clinical sites in the US, Argentina, Canada, Peru, Italy, South Korea, and now Thailand.
[ECOG-ACRIN Cancer Research Group]
Press Release